Researchers have long wondered why some people with high-risk Parkinson’s gene variants develop the disease while others ...

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that ...

CRISPR technology uncovers new key genes and pathways linked to Parkinson’s disease, offering insights into risk and ...

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that ...

A longstanding mystery in Parkinson’s disease research has been why some individuals carrying pathogenic variants that ...

A study led by Northwestern Medicine used CRISPR interference to identify Commander proteins involved in Parkinson’s disease ...

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that ...

Verge Genomics will use digital biomarkers to assess short-term disease progression in an ALS trial testing its VRG50635 ...

Kanazawa University, report in Nature Communications on how the targeted suppression of lysosome function may lead to brain ...

In animal models, NU-9 was found to show promise in treating Alzheimer's by reducing toxic protein buildup and brain ...

Experimental drug NU-9 - a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS) - improves ...

Experimental drug NU-9 -- a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS) -- improves ...